PT Maja Agung Latexindo Tbk

PT Maja Agung Latexindo Tbk

SURI · JK · Healthcare / Medical Instruments & Supplies

65.00IDR+1.00 (+1.56%)

Price History

Full chart

Market Stats

Previous Close64.00
Open64.00
Day Range63.00 – 66.00
52-Week Range50.00 – 118.00
Volume527.40K
Market Cap538.42B
P/E (TTM)566.67
Forward P/E0.00
EPS0.15
Dividend Yield0.00%
Beta-0.96
50-Day Avg79.16
200-Day Avg75.32

About

PT Maja Agung Latexindo Tbk engages in the manufacture and sale of gloves in Indonesia. The company provides examination gloves, industrial gloves, and specialty gloves; and concentrated latex. It serves the medical and healthcare, industrial, and beauty care industries. The company also exports its products. PT Maja Agung Latexindo Tbk was founded in 1988 and is based in Deli Serdang, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Imelda Lin
  • Employees126
  • HeadquartersJalan Utama No. 98, Deli Serdang, Indonesia, 20352, Indonesia
  • Websitehttps://malgloves.com

Leadership

  • Ms. Imelda LinPresident Director · b. 1981
  • Henry PatunruFinance Director, Corporate Secretary & Director · b. 1983
  • Sivaprakash Sasthavu ChettiyarOperational Director & Director · b. 1969
  • Engel StefanMarketing Director & Director · b. 1983

Financials

Income Statement

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue313.37B338.13B93.33B81.72B116.67B150.24B
Growth (%)-+7.90%-72.40%-12.44%+42.77%+28.77%
Cost of Revenue261.10B282.50B77.97B66.78B106.20B142.20B
Gross Profit52.28B55.63B15.36B14.93B10.47B8.04B
Gross Margin16.68%16.45%16.46%18.28%8.97%5.35%
Operating Expense18.56B23.39B20.18B14.19B14.33B12.82B
Operating Income33.71B32.24B-4.82B744.64M-3.86B-4.78B
Operating Margin10.76%9.53%-5.16%0.91%-3.31%-3.18%
EBITDA33.79B34.58B-5.11B978.07M-1.59B-1.46B
EBITDA Margin10.78%10.23%-5.47%1.20%-1.36%-0.97%
Net Income28.82B26.43B10.23B5.47B-3.87B-3.38B
Net Income Margin9.20%7.82%10.96%6.69%-3.32%-2.25%
Interest Expense116.92M222.26M76.63M56.18M161.07M237.07M
Interest Expense % of Total Revenue0.04%0.07%0.08%0.07%0.14%0.16%

Balance Sheet

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets220.93B216.08B187.80B407.96B398.62B386.50B
Total Liabilities154.13B122.82B84.35B61.39B55.45B46.04B
Total Equity66.81B93.26B103.44B346.57B343.17B340.46B
Cash54.26B237.21M292.15M69.92B1.26B672.69M
Total Debt21.02B7.08B--1.13B1.58B
Net Debt-33.24B6.84B-292.15M-69.92B-130.25M912.30M

Cash Flow

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.96B9.70B7.02B-93.46B4.64B1.05B
Investing Cash Flow-2.95B-18.26B-28.32M-50.14B-73.28B-942.28M
Financing Cash Flow45.09B-45.46B-6.93B213.22B-16.00M-704.25M
Capital Expenditure2.95B18.26B28.32M50.14B73.04T942.28M
Free Cash Flow-2.95B-18.26B-28.32M-50.14B-73.03T112.46M
FCF to OCF-24.63%-188.28%-0.40%53.65%-1572306.25%10.66%

Key Statistics & Ratios

Market Cap538.42B
Enterprise Value489.28B
Trailing P/E566.67
Forward P/E0.00
Price / Sales3.42
Price / Book1.56
EPS0.15
Book Value54.65
Revenue (TTM)157.52B
Gross Profit (TTM)13.33B
EBITDA4.77B
Profit Margin0.60%
Operating Margin6.51%
Return on Equity0.27%
Return on Assets0.15%
Shares Outstanding6.33B
Shares Float878.26M
Beta-0.96
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%